| PeterB 2005-09-28, 9:42 am |
|
Mark Probert wrote:
> PeterB wrote:
>
> Lessee...Rich said that an anti-body titre is an excellent marker for
> immunity and you said that an anti-body titre is not the equivalent to
> immunization. Rich never claimed that it was. It is a *marker* showing
> the response to the vaccination. It does measure immunity but in itslef
> it is not an immunization.
Mark, that is not in your script. It is correct, however. See if Rich
agrees with you. Rich?
>
>
> In absolute numbers, no. Relatively speaking, it is, when you compare it
> to the overall monies involved.
Glad to have you back, Mark.
>
> That's the level of revenue
>
> How much are they taking in overall? How much do they have to spend to
> take in that much? Is it a profitable margin? And, of course, you are
> using sales, not profits. That may change the entire outlook.
Yes, there are profits for Merck or they wouldn't continue to
manufacture vaccine. And you don't jetison a profitable business unless
it becomes unprofitable.
>
>
> Can you show the profit margin on vaccines as compared to a drug like
> viagra?
Margins vary, so what? No company would be selling more than one
product if they only kept their best performer. There is no logical
basis for your question.
PeterB
|